Amgen, Allergan apply for European nod for Avastin biosimilar

Dec 2 (Reuters) - Amgen Inc and Allergan Plc said they have submitted an application to the European health regulator seeking approval of their biosimilar version of Roche Holding AG's blockbuster cancer treatment, Avastin.